1Adlercreutz, H (2002) Phyto-oestrogens and cancer. Lancet Oncol 3, 364–373.
2Ford, D (2002) Mechanistic explanations for the chemopreventive action of soyabean isoflavones: reducing the possibilities. Br J Nutr 88, 439–441.
3Verdrengh, M, Jonsson, IM, Holmdahl, R, et al. (2003) Genistein as an anti-inflammatory agent. Inflamm Res 52, 341–346.
4Register, TC, Cann, JA, Kaplan, JR, et al. (2005) Effects of soy isoflavones and conjugated equine estrogens on inflammatory markers in atherosclerotic, ovariectomized monkeys. J Clin Endocrinol Metab 90, 1734–1740.
5Ryan-Borchers, TA, Park, JS, Chew, BP, et al. (2006) Soy isoflavones modulate immune function in healthy postmenopausal women. Am J Clin Nutr 83, 1118–1125.
6Nasca, MM, Zhou, JR & Welty, FK (2008) Effect of soy nuts on adhesion molecules and markers of inflammation in hypertensive and normotensive postmenopausal women. Am J Cardiol 102, 84–86.
7Coussens, LM & Werb, Z (2002) Inflammation and cancer. Nature 420, 860–867.
8James, MJ, Gibson, RA & Cleland, LG (2000) Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr 71, 343S–348S.
9Maskarinec, G, Morimoto, Y, Hebshi, S, et al. (2006) Serum prostate-specific antigen but not testosterone levels decrease in a randomized soy intervention among men. Eur J Clin Nutr 60, 1423–1429.
10Garofalo, C & Surmacz, E (2006) Leptin and cancer. J Cell Physiol 207, 12–22.
11Tilg, H & Wolf, AM (2005) Adiponectin: a key fat-derived molecule regulating inflammation. Expert Opin Ther Targets 9, 245–251.
12Ishihara, K & Hirano, T (2002) IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev 13, 357–368.
13Albert, MA, Glynn, RJ, Buring, J, et al. (2004) C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study). Am J Cardiol 93, 1238–1242.
14Gerhardt, CC, Romero, IA, Cancello, R, et al. (2001) Chemokines control fat accumulation and leptin secretion by cultured human adipocytes. Mol Cell Endocrinol 175, 81–92.
15Sartipy, P & Loskutoff, DJ (2003) Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci U S A 100, 7265–7270.
16Maskarinec, G, Aylward, AG, Erber, E, et al. (2008) Soy intake is related to a lower body mass index in adult women. Eur J Nutr 47, 138–144.
17Gonzalez, C, Cava, F, Ayllon, A, et al. (2001) Biological variation of interleukin-1β, interleukin-8 and tumor necrosis factor-α in serum of healthy individuals. Clin Chem Lab Med 39, 836–841.
18Lamartiniere, CA, Cotroneo, MS & Fritz, WA (2002) Genistein chemoprevention: timing and mechanisms of action in murine mammary and prostate. J Nutr 132, 552S–558S.
19Phipps, WR, Wangen, KE, Duncan, AM, et al. (2001) Lack of effect of isoflavonic phytoestrogen intake on leptin concentrations in premenopausal and postmenopausal women. Fertil Steril 75, 1059–1064.
20Hall, WL, Vafeiadou, K, Hallund, J, et al. (2005) Soy-isoflavone-enriched foods and inflammatory biomarkers of cardiovascular disease risk in postmenopausal women: interactions with genotype and equol production. Am J Clin Nutr 82, 1260–1268.
21Yildiz, MF, Kumru, S, Godekmerdan, A, et al. (2005) Effects of raloxifene, hormone therapy, and soy isoflavone on serum high-sensitive C-reactive protein in postmenopausal women. Int J Gynaecol Obstet 90, 128–133.
22Jenkins, DJ, Kendall, CW, Jackson, CJ, et al. (2002) Effects of high- and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women. Am J Clin Nutr 76, 365–372.
23Campbell, CG, Brown, BD, Dufner, D, et al. (2006) Effects of soy or milk protein during a high-fat feeding challenge on oxidative stress, inflammation, and lipids in healthy men. Lipids 41, 257–265.
24Considine, RV, Sinha, MK, Heiman, ML, et al. (1996) Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334, 292–295.
25Malavazos, AE, Cereda, E, Morricone, L, et al. (2005) Monocyte chemoattractant protein 1: a possible link between visceral adipose tissue-associated inflammation and subclinical echocardiographic abnormalities in uncomplicated obesity. Eur J Endocrinol 153, 871–877.
26Yamashita, T, Sasahara, T, Pomeroy, SE, et al. (1998) Arterial compliance, blood pressure, plasma leptin, and plasma lipids in women are improved with weight reduction equally with a meat-based diet and a plant-based diet. Metabolism 47, 1308–1314.
27Troseid, M, Lappegard, KT, Claudi, T, et al. (2004) Exercise reduces plasma levels of the chemokines MCP-1 and IL-8 in subjects with the metabolic syndrome. Eur Heart J 25, 349–355.
28Ghanim, H, Aljada, A, Hofmeyer, D, et al. (2004) Circulating mononuclear cells in the obese are in a proinflammatory state. Circulation 110, 1564–1571.
29Kim, CS, Park, HS, Kawada, T, et al. (2006) Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters. Int J Obes (Lond) 30, 1347–1355.
30Reape, TJ & Groot, PH (1999) Chemokines and atherosclerosis. Atherosclerosis 147, 213–225.
31Xu, H, Barnes, GT, Yang, Q, et al. (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112, 1821–1830.